Heart Failure with Preserved Ejection Fraction: Definition, Uses, and Clinical Overview

Heart Failure with Preserved Ejection Fraction Introduction (What it is)

Heart Failure with Preserved Ejection Fraction is a type of heart failure where the heart’s pumping strength is relatively normal.
It describes symptoms and signs of heart failure even though the left ventricular ejection fraction is usually 50% or higher.
It is commonly used in cardiology clinics, hospitals, and imaging reports to classify heart failure and guide evaluation.
It is often discussed when shortness of breath, fluid retention, or exercise intolerance occurs without a “weak pump” on echocardiogram.

Why Heart Failure with Preserved Ejection Fraction used (Purpose / benefits)

Heart failure is not a single disease; it is a clinical syndrome (a recognizable pattern of symptoms, exam findings, and test results) caused by many possible heart and vascular problems. Heart Failure with Preserved Ejection Fraction is used to describe the subgroup in which the heart’s squeezing function looks preserved, but the filling function and overall cardiovascular reserve are impaired.

Key purposes and benefits of using the term include:

• Clear classification of heart failure type. Separating Heart Failure with Preserved Ejection Fraction from heart failure with reduced ejection fraction helps clinicians communicate what the heart is doing mechanically and what problems are most likely driving symptoms.
• More focused diagnostic thinking. With preserved ejection fraction, the differential diagnosis often emphasizes elevated filling pressures, diastolic dysfunction (impaired relaxation and stiffness), atrial and pulmonary vascular contributions, and systemic comorbidities.
• Structured symptom evaluation. The label helps organize evaluation of common complaints like breathlessness on exertion, swelling, fatigue, and reduced exercise capacity when systolic function appears normal.
• Risk stratification and monitoring. Once identified, clinicians can follow symptom burden, volume status, rhythm, blood pressure patterns, and comorbidities over time, recognizing that outcomes vary by clinician and case.
• Appropriate therapy selection and avoidance of mismatched assumptions. Many therapies used in reduced ejection fraction heart failure do not map perfectly onto preserved ejection fraction physiology, so naming the condition helps align expectations and care planning.

In short, Heart Failure with Preserved Ejection Fraction addresses the clinical problem of “heart failure symptoms without a low ejection fraction,” prompting a tailored workup and a management strategy that often centers on congestion control, comorbidity treatment, and careful reassessment.

Clinical context (When cardiologists or cardiovascular clinicians use it)

Clinicians commonly reference Heart Failure with Preserved Ejection Fraction in situations such as:

• Shortness of breath, exercise intolerance, or fatigue with an echocardiogram showing preserved left ventricular ejection fraction
• Recurrent fluid overload (leg swelling, abdominal bloating, pulmonary congestion) without clear systolic pump failure
• Longstanding hypertension with left ventricular hypertrophy (thickened heart muscle) and symptoms of congestion
• Atrial fibrillation with worsening exertional capacity or episodes of decompensation
• Older adults with multiple comorbidities (for example obesity, diabetes, chronic kidney disease) and unexplained dyspnea
• Evaluation of pulmonary hypertension where left-sided filling pressures may be contributing
• Hospital admissions for “acute decompensated heart failure” where ejection fraction is preserved on imaging
• Diagnostic clarification when symptoms overlap with lung disease, anemia, deconditioning, or medication effects

Heart Failure with Preserved Ejection Fraction is not an anatomical structure. It is a clinical diagnosis that is assessed through symptoms, physical examination, imaging (most often echocardiography), and supportive laboratory and hemodynamic data when needed.

Contraindications / when it’s NOT ideal

Heart Failure with Preserved Ejection Fraction is a useful clinical category, but it is not always the best label or the most accurate explanation for a patient’s symptoms. Situations where it may be “not ideal” include:

• Reduced or mildly reduced ejection fraction. If left ventricular ejection fraction is below the preserved range, clinicians usually use other categories (such as reduced or mildly reduced ejection fraction) because the underlying physiology and evidence base can differ.
• Symptoms primarily explained by non-cardiac conditions. Lung disease, severe anemia, thyroid disease, deconditioning, medication side effects, and anxiety can mimic heart failure symptoms. In such cases, labeling symptoms as Heart Failure with Preserved Ejection Fraction may be misleading unless cardiac congestion or elevated filling pressures are demonstrated.
• Primary valvular disease as the dominant problem. Severe aortic stenosis, severe mitral regurgitation, or other major valve disorders can cause heart failure symptoms with preserved ejection fraction; clinicians often emphasize the valve diagnosis because it drives treatment decisions.
• Constrictive pericarditis or infiltrative/restrictive cardiomyopathies. These can present with preserved ejection fraction and congestion but have distinct diagnostic clues and management pathways.
• Unclear evidence of elevated filling pressures. Heart failure diagnoses generally require evidence that symptoms are due to cardiac congestion or abnormal pressures. When that evidence is absent, clinicians may avoid committing to the diagnosis and continue evaluation.
• Acute volume overload from non-cardiac causes. Kidney failure, excessive intravenous fluids, certain endocrine conditions, or liver disease can cause swelling and congestion; the best label depends on the dominant mechanism, and varies by clinician and case.

How it works (Mechanism / physiology)

Heart Failure with Preserved Ejection Fraction can be understood as a mismatch between what the body needs during rest or exertion and what the cardiovascular system can deliver without generating abnormally high pressures.

Mechanism, physiologic principle, or measurement concept

• Preserved ejection fraction does not mean normal heart function. Ejection fraction is the percentage of blood the left ventricle ejects with each beat. In Heart Failure with Preserved Ejection Fraction, the percentage can remain in a preserved range, yet the absolute filling, compliance, and pressure dynamics may be abnormal.
• A central concept is elevated filling pressure. Many patients have increased left ventricular diastolic pressures (pressure during filling) and increased left atrial pressures, especially during exercise or fluid shifts. These pressures can transmit backward to the lungs, contributing to shortness of breath.
• Diastolic dysfunction is common. “Diastolic” refers to relaxation and filling. A stiff or slow-relaxing ventricle may fill at higher pressures, even if it still squeezes well.
• Reduced cardiovascular reserve contributes. During exertion, the heart may be less able to increase filling without large pressure rises, and the peripheral circulation may be less able to accommodate increased blood flow.

Relevant cardiovascular anatomy and tissues involved

• Left ventricle (LV). The LV may be thickened (hypertrophy) from hypertension or other stressors. Increased stiffness can impair filling.
• Left atrium (LA). The LA often enlarges over time as it faces higher filling pressures. Atrial fibrillation can further reduce efficient filling and worsen symptoms.
• Pulmonary veins and lungs. Elevated LA pressure can increase pulmonary venous pressure, contributing to pulmonary congestion and breathlessness.
• Right heart and pulmonary vasculature. Chronic left-sided pressure elevation can affect the right ventricle and pulmonary arteries, sometimes leading to right-sided congestion (swelling, fluid retention).
• Systemic contributors. Blood pressure, vascular stiffness, kidney function, inflammation, and metabolic factors can influence volume status and pressures.

Time course, reversibility, and interpretation

Heart Failure with Preserved Ejection Fraction is often chronic, with episodes of worsening (“decompensation”) triggered by salt/fluid shifts, infections, arrhythmias, uncontrolled blood pressure, kidney dysfunction, or medication changes. Some contributors (like volume overload, uncontrolled hypertension, or atrial fibrillation rate issues) may be partially reversible, while structural changes (like hypertrophy or atrial enlargement) may improve slowly or remain persistent. Clinical interpretation commonly integrates symptoms, congestion status, imaging findings, and—when needed—functional or hemodynamic testing.

Heart Failure with Preserved Ejection Fraction Procedure overview (How it’s applied)

Heart Failure with Preserved Ejection Fraction is not a single procedure or device. It is a clinical diagnosis and care framework. A typical high-level workflow looks like this:

1. Evaluation / exam – Review of symptoms: exertional shortness of breath, fatigue, reduced activity tolerance, swelling, nighttime breathing difficulty – Medical history focusing on hypertension, diabetes, obesity, kidney disease, atrial fibrillation, coronary disease, and prior heart failure episodes – Physical examination for signs of congestion (for example leg edema, elevated neck veins, lung crackles), heart murmurs, and rhythm irregularity

2. Preparation for testing – Selection of tests based on presentation and urgency (outpatient vs inpatient), recognizing that testing choices vary by clinician and case – Medication and fluid status context is considered because it can influence exam findings and test interpretation

3. Intervention / testing (diagnostic assessment) – Echocardiography to assess ejection fraction, chamber size, wall thickness, valve function, and measures that may suggest elevated filling pressures – Electrocardiogram (ECG) to evaluate rhythm (especially atrial fibrillation), prior injury patterns, and conduction abnormalities – Laboratory testing may include markers associated with cardiac wall stress, kidney function, anemia screening, and thyroid function, depending on context – Chest imaging (when clinically used) to look for pulmonary congestion or alternative lung explanations for symptoms – Functional assessment such as exercise testing or cardiopulmonary exercise testing in selected patients to clarify whether symptoms are cardiac, pulmonary, or mixed – Invasive hemodynamic assessment (cardiac catheterization with pressure measurements) in selected complex cases, especially when noninvasive findings are inconclusive or when pulmonary hypertension mechanisms need clarification

4. Immediate checks – Clinicians interpret whether there is convincing evidence of heart failure physiology despite preserved ejection fraction, and whether another dominant diagnosis is present (for example significant valve disease)

5. Follow-up – Ongoing reassessment of symptoms, volume status, rhythm, blood pressure, kidney function, and comorbidities – Adjustments to the care plan over time, recognizing that response and priorities vary by clinician and case

Types / variations

Heart Failure with Preserved Ejection Fraction is a broad category rather than a single uniform disease. Common variations include:

• Chronic stable vs acute decompensated
• Chronic stable: longer-term symptoms that may fluctuate with activity level and comorbidity control

• Acute decompensated: sudden or progressive worsening of congestion leading to urgent evaluation or hospitalization

• Left-sided dominant vs biventricular involvement

• Left-sided dominant: pulmonary congestion and exertional dyspnea are prominent

• Biventricular/right-sided features: swelling, abdominal fluid retention, liver congestion, and more marked exercise limitation may be present, often when pulmonary pressures rise

• Rhythm-related phenotypes

• Atrial fibrillation–associated: symptoms may worsen with loss of coordinated atrial contraction or rapid heart rates

• Sinus rhythm with chronotropic incompetence: some patients cannot increase heart rate appropriately during activity, limiting exercise capacity

• Comorbidity-driven phenotypes

• Hypertension-related remodeling (thickened LV)
• Obesity- and metabolic-associated physiology
• Kidney disease–associated volume sensitivity

• Sleep-disordered breathing as a contributor to symptoms and hemodynamics

• Structural and myocardial disease mimics or subgroups

• Infiltrative or restrictive processes (for example amyloid-related patterns) can present with preserved ejection fraction but require specific diagnostic consideration
• Valvular heart disease can coexist and may be the main driver in some individuals

Clinicians often describe these as “phenotypes” because patients frequently have overlapping mechanisms rather than a single cause.

Pros and cons

Pros:

• Clarifies that heart failure can occur even when ejection fraction is preserved
• Encourages evaluation for elevated filling pressures and diastolic dysfunction
• Provides a shared language for clinicians, trainees, and patients
• Prompts systematic assessment of comorbidities that commonly worsen symptoms
• Helps frame why symptoms can be exertional and variable day to day
• Supports longitudinal monitoring of congestion, rhythm, and functional capacity

Cons:

• The category is broad and can include multiple different underlying diseases
• Symptoms overlap with lung disease, deconditioning, anemia, and other non-cardiac causes
• Diagnostic certainty can be challenging when congestion is intermittent or exercise-related
• Preserved ejection fraction may be misinterpreted by patients as “normal heart” despite ongoing limitations
• Management often requires individualized, multi-condition care rather than a single targeted fix
• Coexisting valve disease or infiltrative conditions can be under-recognized without careful evaluation

Aftercare & longevity

Because Heart Failure with Preserved Ejection Fraction is usually chronic, “aftercare” is best understood as ongoing follow-up and reassessment rather than recovery from a one-time procedure. Outcomes and longevity vary by clinician and case, and are influenced by several general factors:

• Severity and frequency of congestion episodes. Recurrent fluid overload can lead to hospitalizations and progressive limitation.
• Blood pressure and vascular health. Hypertension and arterial stiffness can increase cardiac workload and filling pressures.
• Heart rhythm stability. Atrial fibrillation, rapid rates, or other rhythm problems can worsen symptoms and functional capacity.
• Kidney function and volume sensitivity. The heart–kidney interaction is important; changes in kidney function can affect fluid balance and medication tolerance.
• Comorbidity burden. Obesity, diabetes, sleep-disordered breathing, lung disease, and anemia can amplify symptoms even when cardiac function appears “preserved.”
• Adherence and follow-up. Regular monitoring, reassessment, and coordinated care (often involving primary care and cardiology) can help identify changes early.
• Functional conditioning and rehabilitation. Clinicians may consider supervised exercise or cardiac rehabilitation in selected patients to support safe conditioning and symptom tracking, depending on local availability and individual risk.

Alternatives / comparisons

Heart Failure with Preserved Ejection Fraction is one category within a wider framework for evaluating dyspnea, edema, and exercise limitation. Common comparisons include:

• Heart failure with reduced ejection fraction (HFrEF) vs preserved ejection fraction
• HFrEF features reduced pumping function and often has a different set of medication and device strategies.

• Heart Failure with Preserved Ejection Fraction emphasizes filling pressures, stiffness, atrial and vascular contributions, and comorbidity management. There is overlap, and some patients transition between categories over time.

• Heart failure with mildly reduced ejection fraction

• Some patients fall into an intermediate ejection fraction range. Clinicians may use a blended approach, and categorization can change with measurement variability and clinical course.

• Non-cardiac causes of similar symptoms

• Chronic lung disease, pulmonary embolism, anemia, thyroid disorders, and deconditioning can resemble heart failure. In unclear cases, additional testing is used to distinguish primary drivers.

• Noninvasive vs invasive evaluation

• Echocardiography, ECG, labs, and functional testing are typical starting points.

• Invasive hemodynamic testing may be considered when noninvasive findings are conflicting or when pulmonary hypertension mechanisms need precise definition.

• Medication-focused management vs procedure-based management

• Many patients are managed primarily with medications and comorbidity treatment.
• Procedures may be relevant when a specific driver is identified (for example a significant valve lesion or a rhythm strategy for atrial fibrillation), but the best approach varies by clinician and case.

Heart Failure with Preserved Ejection Fraction Common questions (FAQ)

Q: Does Heart Failure with Preserved Ejection Fraction mean my heart is “normal”?
No. Preserved ejection fraction means the percentage of blood pumped out with each beat is not markedly reduced, but heart failure symptoms can still occur due to abnormal filling pressures, stiffness, rhythm issues, or vascular factors. Many patients have real, measurable limitations despite a “preserved” ejection fraction reading.

Q: Is Heart Failure with Preserved Ejection Fraction painful?
Heart failure itself is more commonly associated with shortness of breath, fatigue, and swelling than pain. Chest discomfort can occur if there is coexisting coronary artery disease, high filling pressures, or other conditions. Any chest pain concerns are evaluated in clinical context, because causes vary.

Q: How is Heart Failure with Preserved Ejection Fraction diagnosed?
Diagnosis typically combines symptoms and signs of heart failure with evidence of preserved ejection fraction on echocardiogram and supportive findings suggesting elevated filling pressures. Clinicians also work to exclude or identify alternative explanations such as lung disease, valve disease, or anemia. In selected cases, exercise testing or invasive pressure measurements are used when the diagnosis remains uncertain.

Q: Will I need to be hospitalized?
Some people are diagnosed during an emergency visit or hospitalization for acute fluid overload, while others are evaluated entirely as outpatients. Hospitalization risk depends on symptom severity, oxygen status, blood pressure, kidney function, and how much congestion is present. Decisions about location of care vary by clinician and case.

Q: What treatments are used for Heart Failure with Preserved Ejection Fraction?
Management commonly focuses on relieving congestion, controlling blood pressure, addressing rhythm problems (such as atrial fibrillation), and treating contributing comorbidities. Multiple medication classes may be considered depending on the clinical scenario, kidney function, and other factors. Specific plans are individualized and may change over time.

Q: How long do results last once symptoms improve?
Symptom improvement can be durable when contributing factors remain controlled, but Heart Failure with Preserved Ejection Fraction often fluctuates with illness, salt/fluid balance, blood pressure changes, and rhythm disturbances. Many patients experience periods of stability punctuated by exacerbations. Long-term patterns vary by clinician and case.

Q: Is it safe to exercise with Heart Failure with Preserved Ejection Fraction?
Physical activity is often discussed as part of overall conditioning and symptom management, but safety depends on the individual’s symptoms, rhythm, blood pressure response, and comorbidities. Clinicians may recommend structured or supervised programs in selected patients. Activity guidance is individualized rather than one-size-fits-all.

Q: What is the typical cost range for evaluation and follow-up?
Costs vary widely based on location, insurance coverage, testing choices (imaging, labs, stress testing), and whether care occurs in the hospital or outpatient setting. Coexisting conditions can add additional visits and studies. For many people, the main cost drivers are imaging and hospital-based care when exacerbations occur.

Q: Is Heart Failure with Preserved Ejection Fraction the same as diastolic heart failure?
They are related terms, and many clinicians use them similarly, but they are not perfectly identical. “Diastolic dysfunction” describes a physiologic finding (impaired relaxation or stiffness), while Heart Failure with Preserved Ejection Fraction is a clinical syndrome that also involves symptoms, congestion, and often systemic contributors. Some people can have diastolic dysfunction on echocardiogram without meeting criteria for heart failure.